John P Dubinsky's Net Worth

$3.92 Million

Estimate Recalculated Jun 27, 2025 09:07PM EST

Who is John P Dubinsky

John P Dubinsky has an estimated net worth of $3.92 Million. This is based on reported shares across multiple companies, which include INSITUFORM TECHNOLOGIES INC, STIFEL FINANCIAL CORP, and ACCENTIA BIOPHARMACEUTICALS INC.

SEC CIK

John P Dubinsky's CIK is 0001181348

Past Insider Trading and Trends

2004 was John P Dubinsky's most active year for acquiring shares with 11 total transactions. John P Dubinsky's most active month to acquire stocks was the month of December. 2010 was John P Dubinsky's most active year for disposing of shares, totalling 9 transactions. John P Dubinsky's most active month to dispose stocks was the month of November. 2013 saw John P Dubinsky paying a total of $180,600.00 for 15,667 shares, this is the most they've acquired in one year. In 2020 John P Dubinsky cashed out on 35,325 shares for a total of $1,021,726.25, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Aegion Corp

Investor
Updated Aug 28, 2013
Form 4
-24.33%
-5.00K
$22.30
-$111.50K
Aug 28, 2013
41.98K
Sale
Aug 26
Form 4
20.90%
4.57K
May 16, 2013
46.98K
Grant
May 14
Form 4
-19.57%
-5.00K
$20.90
-$104.52K
Dec 13, 2012
42.41K
Sale
Dec 11
Form 4
25.56%
4.78K
May 11, 2012
47.41K
Grant
May 09
Form 4
8.42%
3.31K
Apr 22, 2011
42.63K
Grant
Apr 20
Form 4
9.03%
3.26K
Apr 23, 2010
39.31K
Grant
Apr 21
Form 4
16.97%
5.23K
Apr 24, 2009
36.06K
Grant
Apr 22
Form 4
26.64%
4.35K
Jun 13, 2008
20.67K
Grant
Jun 11
Form 4
28.29%
3.60K
Apr 27, 2007
16.33K
Grant
Apr 25
Form 4
6,578.95%
10.00K
$22.15
$221.51K
Nov 06, 2006
10.15K
Purchase
Nov 02
Form 4
33.60%
3.20K
Apr 28, 2006
12.73K
Grant
Apr 26
Form 4
50.59%
3.20K
Apr 29, 2005
9.53K
Grant
Apr 27
Form 4
102.40%
3.20K
Jul 29, 2004
6.33K
Grant
Jul 28
Form 4
3.13K
Dec 16, 2003
3.13K
Grant
Dec 15
Showing 14 results

STIFEL FINANCIAL CORP

Investor
Updated Jun 04, 2020
Form 4
-12.85%
-2.40K
$51.55
-$123.72K
Jun 04, 2020
16.28K
Sale
Jun 03
Form 4
-27.26%
-7.00K
$46.98
-$328.88K
May 26, 2020
18.68K
Sale
May 21 - May 26
Form 4
May 19, 2020
25.68K
Options
May 15
Form 4
-43.97%
-12.78K
$44.55
-$569.13K
May 11, 2020
16.28K
Sale
May 08
Form 4
Jan 06, 2020
38.46K
Options
Jan 02
Form 4
-7.83%
-2.15K
$56.79
-$122.10K
Sep 11, 2019
25.31K
Sale
Sep 10
Form 4
-5.18%
-1.50K
$54.71
-$82.06K
Sep 05, 2019
27.46K
Sale
Sep 05
Form 4
-6.46%
-2.00K
$57.25
-$114.50K
Jun 21, 2019
57.91K
Sale
Jun 19
Form 4
4.50%
1.90K
Jun 07, 2019
44.11K
Options
Jun 05 - Jun 06
Form 4
Jan 04, 2019
45.21K
Options
Jan 02
Form 4
12.66%
1.90K
Sep 27, 2018
16.91K
Grant
Sep 25
Form 4
-11.24%
-1.90K
Aug 07, 2018
15.01K
Disposition
Aug 07
Form 4
4.39%
1.90K
Jun 08, 2018
45.21K
Options
Jun 06 - Jun 07
Form 4
Jan 03, 2018
43.31K
Options
Dec 29
Form 4
-16.68%
-4.54K
Nov 22, 2017
22.66K
Grant
Nov 21
Form 4
10.13%
1.90K
Jun 09, 2017
47.85K
Grant
Jun 07
Form 4/A
-15.27%
-4.00K
$45.15
-$180.60K
Jan 04, 2017
22.19K
Sale
Nov 21
Form 4
Jan 04, 2017
45.95K
Options
Dec 30
Form 4
-17.35%
-5.00K
$50.20
-$251.00K
Nov 23, 2016
45.95K
Sale
Nov 22
Form 4
20.40%
3.75K
Jun 17, 2016
58.95K
Grant
Jun 15
Form 4
Jan 26, 2016
55.20K
Options
Jan 22
Form 4
-1.33%
-450.00
$29.50
-$11.25K
Dec 14, 2015
55.20K
Sale
Dec 11
Form 4
20.83%
3.75K
Jun 12, 2015
55.65K
Grant
Jun 10
Form 4
-4.29%
-1.50K
$55.89
-$83.83K
Mar 13, 2015
51.90K
Sale
Mar 12
Form 4
Jan 23, 2015
53.40K
Options
Jan 22
Form 4
-5.96%
-2.00K
$49.95
-$99.90K
Dec 05, 2014
53.40K
Sale
Dec 03 - Dec 04
Form 4
21.27%
3.75K
Jun 12, 2014
55.40K
Grant
Jun 11
Form 4
Jan 27, 2014
51.65K
Options
Jan 24
Form 4
15.27%
4.00K
$45.15
$180.60K
Nov 25, 2013
51.65K
s
Nov 21
Form 4
-10.28%
-3.00K
$40.00
-$120.00K
Aug 14, 2013
47.65K
Sale
Aug 13
Form 4
21.73%
3.75K
Jun 12, 2013
50.65K
Grant
Jun 12
Form 4
22.25%
3.75K
Mar 18, 2013
50.25K
Grant
Jun 06
Form 4
Jan 25, 2013
43.15K
Options
Jan 24
Form 4
Jan 19, 2012
43.15K
Options
Jan 17
Form 4
19.62%
3.38K
Jun 03, 2011
43.15K
Grant
Jun 01
Form 4
Jan 20, 2011
26.52K
Options
Jan 19
Form 4
-27.93%
-4.70K
$35.73
-$197.15K
Dec 06, 2010
26.52K
Sale
Dec 03
Form 4
18.53%
2.25K
Apr 27, 2010
31.22K
Grant
Apr 23
Form 4
Jan 21, 2010
38.97K
Options
Jan 20
Form 4
-56.82%
-10.00K
$30.53
-$469.49K
Aug 17, 2009
28.97K
Sale
Aug 14
Form 4
16.95%
2.25K
Jun 05, 2009
38.97K
Grant
Jun 03
Form 4
20.42%
1.50K
May 08, 2008
24.48K
Grant
May 06
Form 4
25.42%
1.49K
May 30, 2007
22.98K
Grant
May 14
Form 4
39.28%
1.65K
May 11, 2006
21.49K
Grant
May 09
Form 4
1.00K
Jan 04, 2006
19.83K
Grant
Jan 03
Form 4
86.52%
1.95K
May 12, 2005
18.83K
Grant
May 11
Form 3/A
Apr 08, 2005
3.80K
Form 4
1.00K
Jan 05, 2005
11.82K
Grant
Jan 03
Form 4
417.13%
1.36K
Jun 10, 2004
8.11K
Grant
May 05
Form 4
327.00
Apr 02, 2004
6.75K
Grant
Apr 01
Form 4
1.00K
Mar 04, 2004
6.42K
Grant
Feb 03
Form 4
422.00
$18.52
$6.24K
Jan 05, 2004
5.42K
Grant
Jan 01
Form 3
Nov 13, 2003
Showing 53 results

ACCENTIA BIOPHARMACEUTICALS INC

Investor
Updated Mar 04, 2008
Form 4
60.00K
Mar 04, 2008
60.00K
Grant
Feb 29
Form 4
0.74%
1.05K
$8.00
$8.40K
Jun 23, 2006
143.39K
Acquisition
Apr 03
Form 4
-40.07%
-95.16K
Nov 04, 2005
142.34K
Options
Nov 02
Form 4
45.00K
Oct 31, 2005
45.00K
Grant
Oct 28
Form 3
Oct 27, 2005
237.51K
Showing 5 results